The Alzheimer’s Drug Discovery Foundation (ADDF) and the FINGERS Brain Health Institute (FBHI) have announced a new partnership that will focus on precision preventative measures physicians can take to slow, or potentially prevent, the onset of symptoms in Alzheimer’s disease based on each patient’s molecular profile.
